BioSpace News Archive

HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today highlighted the HTG EdgeSeq Mouse mRNA Tumor Response Panel as a way to identify endogenous targets of cardiac fibrosis as reported in the September 2019 issue of Nature.

Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today commenced its previously announced rights offering to raise gross proceeds of $30.0 million (the “Rights Offering”).

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its fourth-quarter 2019 financial results and business highlights.

Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), today announced that it has filed for Special 510(k) Premarket Notification with the U.S. Food and Drug Administration (“FDA”) for its Generation II Rapid Acoustic Pulse (“RAP”) device.

Company plans to exceed that amount in 2020 to help address housing insecurities and promote community health improvement

Incyte announced that it will present at the Cowen and Company 40th Annual Health Care Conference on Monday, March 2, 2020 at 11:20 a.m. ET in Boston.

Feb. 11, 2020 13:00 UTC PARIS--( BUSINESS WIRE )-- TISSIUM, a privately-owned life science company developing fully synthetic, biomorphic programmable polymers, announced today that they have received funding from the Crohn’s & Colitis Foundation’s IBD Ventures, a funding mechanism intended to accelerate the discovery and development of novel research-based products with the potential to alleviate suffering caused by inflammatory bowel disease (IBD). The funding will support T

Varex Imaging Corporation announced that Clarence Verhoef has informed the company of his intention to retire as senior vice president and chief financial officer.

Varex Imaging Corporation announced its unaudited financial results for the first quarter of fiscal year 2020.

Final results reported from the longest-running clinical trial of an amantadine product in Parkinson’s disease